Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: ACS Comb Sci. 2013 Jun 13;15(7):335–339. doi: 10.1021/co400064d

Parallel Synthesis of 1,6-Disubstituted-1,2,4-Triazin-3-Ones on Solid-Phase

Miao Hu , Wei Huang , Marc A Giulianotti , Richard A Houghten , Yongping Yu †,‡,*
PMCID: PMC3875618  NIHMSID: NIHMS493770  PMID: 23750635

Abstract

A parallel solid-phase synthesis of 1,6-disubstituted-1,2,4-triazin-3-ones from MBHA resin is described. The reduction of resin-bound nitrosamino acids provides hydrazines efficiently without affecting the amide bond. The trityl protected hydrazine is then reduced with borane, and cyclized with 1,1-carbonyldiimidazole. The desired products are cleaved from their solid support and obtained in good yield and purity. This methodology is of value for the rapid parallel preparation of these potentially bioactive molecules.

Keywords: solid-phase; 1,2,4-triazinones; N-nitroso; hydrazine; reduction; cyclization


Solid-phase organic synthesis (SPOS) is a pivotal technique for the rapid access to structurally diverse compounds in the drug discovery process.1 One major focus of this field is on the synthesis of small bioactive molecules and their derivatives on the solid phase. In particular, heterocyclic compounds have received special attention due to their high degree of structural diversity and multiple applications in the treatment of human diseases.2, 3

1,2,4-triazinones are analogues of the pyrimidine bases of nucleic acids and an important class of molecules with several biological properties. For example, 1,2,4-triazin-3(2H)-ones have been shown to possess potential as anticancer,4 antiviral5 and antibacterial drugs.6 Moreover, 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones were reported as orally selective 5-lipoxygenase (5-LO) inhibitors.7 However, to the best of our knowledge, no examples of 1,6-disubstituted-1,2,4-triazin-3-one have been reported in the literature.

In the past decades, the N-nitroso group (N-NO) has attracted much attention because of its pharmaceutical properties and its synthetic utility. 8 It can be used synthetically to generate an N-N bond as well as a hydrazine linker. There are several reagents that can reduce the N-NO group in order to obtain hydrazine, including Zn/AcOH9, LiAH410, or titanium trichloride (TiCl3)11 in solution phase, and LiAH48b, 12 or DIBAL13 on solid-phase. We have found that LiAH4 or DIBAL do not selectively afford hydrazine efficiently when an amide bond is present, even at low temperatures, such as 0 °C with DIBAL (data not shown), since the amide bond will also be reduced. Red-Al is an alternative reductive reagent to LiAH4, and it is much safer and more convenient for storage. While Lee et al.14 have reported the reduction of amide bonds with Red-Al as part of their effort to obtain [1, 2]-diamines at room temperature, it was believed that the conditions could be optimized in order to selectively reduce N-NO over amide bonds.

Herein, a synthetic strategy in which Red-Al is highly efficient and selective at reducing N-NO over amides has been developed (Scheme 1). From the LC-MS data, the crude product A was obtained with 95% purity (tR = 5.214 min). Only 3% of the amide bond was reduced (tR = 6.227 min) (Figure 1). The isolated yield of A was 88%.

Scheme 1.

Scheme 1

Synthesis approach for hydrazine on solid-phase

Figure 1.

Figure 1

LC-MS data of crude product A

Moreover, through the use of a reductive alkylation, diverse substitutions were generated on the N1 position of hydrazine (Table 1). As a note, it was observed that the 4-OBn-Bn group was cleaved from the hydrazine moiety by HF (Scheme 2), which provided us a new method for obtaining N1 (H)-hydrazine. The isolated yield of B was 82%. Additionally, B was characterized by LC-MS, HRMS, 1H NMR and 13C NMR (see supporting information).

Table 1.

Individual products of 1,6-disubstituted-1, 2,4-triazin-3-ones

graphic file with name nihms493770u1.jpg
compound R1 R2 massa [M+H]+ tRb (min) Purityc (%) HRMS [M+H]+ yieldd (%)
9a Benzyl Phenyl 281.9 5.60 92 282.1606 64
9b 4-F-Benzyl Phenyl 299.9 5.72 90 300.1514 71
9c 4-OCH3Benzyl Phenyl 311.9 5.58 88 312.1645 69
9d 1-Naphthyl-CH2e Phenyl 332.0 6.22 70 332.1761 56
9e 2-Naphthyl-CH2f Phenyl 331.9 6.26 92 332.1759 64
9f H Phenyl 191.9 4.01 88 192.1133 64
9g CH(CH3)2 Phenyl 234.0 5.43 80 234.1604 60
9h CH2CH(CH3)2 Phenyl 248.0 5.73 85 248.1758 68
9i CH3 Phenyl 205.9 4.33 81 206.1294 70
9j Benzyl 4-Br-Phenyl 359.7 6.18 69 360.0712 60
361.7 362.0693
9k CH3 4-Br-Phenyl 283.7 5.03 55 284.0399 65
285.7 286.0381
9l Benzyl 2-F-Phenyl 299.9 5.63 88 300.1515 70
9m CH3 2-F-Phenyl 223.9 4.37 93 224.1197 82
9n Benzyl 2-Naphthyl 332.0 6.28 80 332.1761 65
9o CH3 2-Naphthyl 255.9 5.21 90 256.1447 68
9’a Benzyl 4-OBnPhenyl 191.9 3.98 40 192.1136 68
9’b 4-F-Benzyl 4-OBnPhenyl 209.9 4.16 55 210.1042 70
9’c 4-OCH3Benzyl 4-OBnPhenyl 221.9 4.01 28 222.1139 64
9’d 1-Naphthyl-CH2e 4-OBnPhenyl 241.9 4.72 58 242.1293 61
9’e 2-Naphthyl-CH2f 4-OBnPhenyl 241.9 4.80 63 242.1298 61
a

Confirmed by mass spectra (ESI).

b

Retention times from analytical RP-HPLC profile (UV detection at 214 nm and 254 nm).

c

The purity of the crude material was estimated by the peak area from analytical RP-HPLC traces at λ = 254 nm and 214 nm.

d

Isolated yield based on manufacturer’s loading of MBHA resin.

e

1-Naphthyl-CH2:

e

f

2-Naphthyl-CH2:

f

Scheme 2.

Scheme 2

Synthesis approach for N1 (H)-hydrazine on solid-phase

To extend the practical value of this methodology for the production of a hydrazine moiety, it was applied to the synthesis of 1,6-disubstituted-1,2,4-triazin-3-ones (Scheme 3). Starting from p-methylbenzhydrylamine (MBHA) resin 1, a Boc-amino acid was coupled to the resin using a standard DIC/HOBt procedure to generate the resin bound amino acid 2. After removal of the Boc group with 55% TFA in DCM, a reductive alkylation was performed in order to introduce a secondary diversity15 (3). Subsequent reaction with tert-Butyl nitrite led to the resin-bound nitroso compound 4. The hydrazine 5 was then generated by reducing 4 with Red-Al at room temperature. The hydrazine was protected with a Trt group due to its reported instability to BH3/THF.13 The corresponding resin-bound product 7 was treated with 2% TFA/DCM and cyclized with 1,1-carbonyldiimidazole, which was then released from the resin by HF at 0 °C. Afterwards, the final products 9 (or 9’) were obtained in good yields and purity.

Scheme 3.

Scheme 3

Synthesis of 1,6-disubstituted-1,2,4-triazin-3-ones. Reagents and Conditions: (a) (i) prewash with 5% DIEA/DCM; (2) Boc-AA-OH, DIC, HOBT, DMF, r.t., 2 h; (b) (i) 55%TFA/DCM; (ii) reductive alkylation, R2CHO; (c) 0.5 M tert-Butyl nitrite/THF, 60 °C, 24 h; (d) Red-Al, THF, r.t., overnight; (e) TrtCl, DIPEA, DMF, DCM; (f) BH3/THF, 60 °C; (g) (i) 2% TFA/DCM; (ii) 1,1-carbonyldiimidazole, DCM; (h) HF, 0 °C, 1.5 h; (i) HF, 0 °C, 1.5 h.

As outlined in Table 1, several amino acids and different aldehydes were accessed for viability under the synthetic conditions. When R2 was Phenyl, amino acids with an aromatic side chain generated products with slightly higher purity than those with alkyl side chains according to the HPLC data of the crude products (9a-9e to 9f-9i, except 9d, which may be due to the 1-naphthyl hindering the cyclization). When R2 contained the electron-withdrawing group 2-Fluoro on the Phenyl ring, the purity was excellent (9l and 9m). However, the situation was different when 4-Bromo was present (9j and 9k). This may be the result of dehalogenation of the Bromo during the Red-Al reduction reaction. When the electron-donating group 4-OBn was present on the Phenyl ring (9’a-9’e), the entire 4-OBn-Bn group was cleaved from the product during the HF step. Low purity products were obtained for these compounds (9’a-9’e). The overall yield for the analogs tested under the described conditions ranged from 56%-82% (Table 1).

In conclusion, the reduction of an N-NO group on the solid-phase affords a facile approach for producing amino acids with hydrazine termini and a reductive alkylation provides a second diversity position. Moreover, these synthetic methods can be applied to the efficient parallel synthesis of novel 1,6-disubstituted-1,2,4-triazin-3-ones. This methodology is of value for the rapid parallel preparation of these potentially bioactive molecules in drug discovery.

Experimental Procedures

General Methods

Reagents were obtained from commercial sources and used without any further purification. Solvents were purchased from Sigma-Aldrich and were used directly. The isolated yields were based on the manufacturer’s loading of MBHA resin. LC-MS (APCI and ESI) were recorded on a Shimadzu LCMS-2010EVat LCQ mass spectrometer (ThermoQuest Corporation) using a Phenomenex Luna 5 μ C18, 100 Å, 150 × 4.60 mm 5 micron column running a 5-95 (H2O/CH3CN; 0.1% formic acid) gradient over 6 min. Preparative RP-HPLC was performed on a Shimadzu LC-8A preparative HPLC using a Phenomenex Luna 5 μ C18 (2) 100 Å column (75 × 21.2 mm, 5 micron). High resolution mass spectra were measured on an Agilent 1290 HPLC-6224 Time of Fight Mass Spectrometer. 1H NMR and 13C NMR spectra were recorded at 400 MHz on a Bruker Advance spectrometer with a 5-mm inverse gradient probe.

General Procedures for the Synthesis 1, 6-Disubstituted-1, 2, 4-Triazin-3-Ones (9a-9o, 9’a-9’e)

100 mg of MBHA resin (1.1 meq/g) was contained in a polypropylene mesh packet. Following neutralization with 5% diisopropylethylamine (DIEA), the resin was coupled with Boc-amino acid, hydroxybenzotriazole (HOBt, 6.0 equiv, 0.1 M) and diisopropylcarbodiimide (DIC, 6.0 equiv, 0.1 M) in DMF at room temperature for 2 h. Upon removal of the Boc group with 55% TFA in DCM (30 min), the resin was washed with DCM (2 times), neutralized with a solution of 5% DIEA in DCM. Reductive alkylation was performed according to the general methods. AcOH (0.11 mL) and trimethyl orthoformate (TMOF) (0.55 mL) were added to a mixture of resin in DCM (8.1 mL) and MeOH (2.2 mL). The appropriate aromatic aldehyde (10 equiv) was added to the above solution and shaken for 20 min. NaCNBH3 (69 mg, 10 equiv) in DMF (1.1 mL) was added and the mixture was shaken for 1 h at room temperature. The resin was then washed with DMF, DCM, 5% DIEA/DCM, DCM and MeOH, and dried in the hood. The resulting resin bound amine was treated with 0.5 M tert-Butyl nitrite in THF at 60 °C for 24 h. The bag was washed with THF, DCM, MeOH, and dried in vacuo. The resulting resin-bound nitrosamino acid was then reduced with 0.5 M Red-Al (70% in toluene) in THF. The reduction solution was poured off and quenched with methanol before adding to waste, and then washed bags with THF and MeOH several times. The corresponding resin-bound hydrazine was reacted with TrtCl (10 equiv) and DIEA (20 equiv) in 0.1 M 10% DMF/DCM. The resin was washed with DMF and DCM twice. After the Trt protection, the resin was reduced in BH3/THF at 60 °C for four days and then with piperidine at 60 °C for one day. The bags were then washed with DMF (twice), DCM (four times) and MeOH (twice). After removal of the Trt group in 2% TFA/DCM (3 × 10 min), the resin was cyclized with 1,1-carbonyldiimidazole (6 equiv) in DCM. The final product was then released from the resin by anhydrous HF in the presence of 0.5% anisole at 0 °C for 1.5 h. The product was extracted by 95% acetic acid in water. After lyophilization, the product of 1,6-disubstituted-1,2,4-triazin-3-one was obtained. The crude product was purified by preparative HPLC and characterized by LC-MS under ESI conditions, HRMS and NMR spectroscopy.

Supplementary Material

1_si_001

Acknowledgments

Funding

This work was supported in part by The Project of Science Technology Department of Zhejiang Province (2012C33065), the Project of Education Department of Zhejiang Province (Y201223193), NIH Grant 1R01DA031370, the State of Florida, Executive Office of the Governor’s Office of Tourism, Trade, and Economic Development, and the Osteoporosis and Breast Cancer Research Center.

Footnotes

Supporting Information

Experimental data for compounds A, B, 9a-9o, 9’a-9’b, and 1H, 13C NMR spectra. This material is available free of charge via Internet at http://pubs.acs.org.

The authors declare no competing financial interest.

References

  • 1.(a) Houghten RA, Pinilla C, Appel JR, Blondelle SE, Dooley CT, Eichler J, Nefzi A, Ostresh JM. Mixture-Based Synthetic Combinatorial Libraries. J Med Chem. 1999;42:3743–3777. doi: 10.1021/jm990174v. [DOI] [PubMed] [Google Scholar]; (b) Gil C, Bräse S. Solid-Phase Synthesis of Biologically Active Benzoannelated Nitrogen Heterocycles: An Update. J Comb Chem. 2009;11:175–197. doi: 10.1021/cc800102t. [DOI] [PubMed] [Google Scholar]
  • 2.Franzén RG. Recent advances in the preparation of heterocycles on solid support: A review of the literature. J Comb Chem. 2000;2:195–214. doi: 10.1021/cc000002f. [DOI] [PubMed] [Google Scholar]
  • 3.Nefzi A, Ostresh JM, Houghten RA. The current status of heterocyclic combinatorial libraries. Chem Rev. 1997;97:449–472. doi: 10.1021/cr960010b. [DOI] [PubMed] [Google Scholar]
  • 4.(a) Wotring LL, Townsend LB. Identification of 6-Azauridine Triphosphate in LI 210 Cells and Its Possible Relevance to Cytotoxicity. Cancer Res. 1989;49:289–294. [PubMed] [Google Scholar]; (b) Mishra RC, Dwivedi N, Bansal I, Saxena JK, Tripathi RP. Synthesis and DNA Topoisomerase-II Inhibitory Activity of Unnatural Nucleosides. Nucleosides, Nucleotides & Nucleic Acids. 2005;24:15–35. doi: 10.1081/NCN-46776. [DOI] [PubMed] [Google Scholar]
  • 5.(a) Morrey JD, Smee DF, Sidwell RW, Tseng C. dentification of active antiviral compounds against a New York isolate of West Nile virus. Antiviral Res. 2002;55:107–116. doi: 10.1016/s0166-3542(02)00013-x. [DOI] [PubMed] [Google Scholar]; (b) Kabbaj Y, Lazrek HB, Barascut JL, Imbach JL. Synthesis and Biological Activity of Some Unsaturated 6-Azauracil Acyclonucleosides. Nucleosides, Nucleotides & Nucleic Acids. 2005;24:161–172. doi: 10.1081/NCN-55695. [DOI] [PubMed] [Google Scholar]
  • 6.(a) Khalil NSAM, Mansour AK, Eid MM. Synthesis of Some Novel 6-Benzyl(or Substituted Benzyl)-2-β-d-Glucopyranosyl-1, 2, 4-Triazolo[4, 3-b] [1, 2, 4] Triazines as Potential Antimicrobial Chemotherapeutics. Nucleosides, Nucleotides & Nucleic Acids. 2004;23:1889–1910. doi: 10.1081/NCN-200040663. [DOI] [PubMed] [Google Scholar]; (b) Modzelewska-Banachiewicz B, Kamińska T. Antiviral activity of the products of cyclization of dimethyl 2-[(1-arylamino-1-arylmethylidene)hydrazono] succinate. Eur J Med Chem. 2001;36:93–99. doi: 10.1016/s0223-5234(00)01201-0. [DOI] [PubMed] [Google Scholar]
  • 7.Bhatia PA, Brooks CDW, Basha A, Ratajczyk JD, Gunn BP, Bouska JB, Lanni C, Young PR, Bell RL, Carter GW. 5-Lipoxygenase Inhibitors: Synthesis and Structure-Activity Relationships of a Series of 1-Aryl-2H, 4H-tetrahydro-1, 2, 4-triazin-3-ones. J Med Chem. 1996;39:3938–3950. doi: 10.1021/jm960372b. [DOI] [PubMed] [Google Scholar]
  • 8.(a) Luinsky W, Keefer L, Loo J. The preparation and properties of some nitrosamino acids. Tetrahedron. 1970;26:5137–5153. doi: 10.1016/s0040-4020(01)93166-7. [DOI] [PubMed] [Google Scholar]; (b) Lazny R, Nodzewska A, Zabicka B. Asymmetric Solid-Phase Alkylation of Ketones Immobilized via SAMP Hydrazone Analogue Linkers. J Comb Chem. 2008;10:986–991. doi: 10.1021/cc8001298. [DOI] [PubMed] [Google Scholar]
  • 9.Zanka A. Process Development of a Platelet Aggregation Inhibitor. Organic Process Research & Development. 1998;2:418–421. [Google Scholar]
  • 10.Nurminen EM, Pihlavisto M, Lázár L, Pentikäinen U, Fülöp F, Pentikäinen OT. Novel Hydrazine Molecules as Tools To Understand the Flexibility of Vascular Adhesion Protein-1 Ligand-Binding Site: Toward More Selective Inhibitors. J Med Chem. 2011;54:2143–2154. doi: 10.1021/jm200059p. [DOI] [PubMed] [Google Scholar]
  • 11.Lunn G, Sansone EB. Reduction of Nitrosamines with Aqueous Titanium Trichloride: Convenient Preparation of Aliphatic Hydrazines. J Org Chem. 1984;49:3470–3473. [Google Scholar]
  • 12.Enders D, Kirchhoff JH, Köbberling J, Peiffer TH. Asymmetric Synthesis of α-Branched Primary Amines on Solid Support via Novel Hydrazine Resins. Org Lett. 2001;3:1241–1244. doi: 10.1021/ol015721x. [DOI] [PubMed] [Google Scholar]
  • 13.Kirchhoff JH, Bräse S, Enders D. A Novel Hydrazine Linker Resin and Its Application for the Solid-Phase Synthesis of α-Branched Primary Amines. J Comb Chem. 2001;3:71–77. doi: 10.1021/cc000062l. [DOI] [PubMed] [Google Scholar]
  • 14.Lee RE, Protopopova M, Crooks E, Slayden RA, Terrot M, Barry CE., III Combinatorial Lead Optimization of [1, 2]-Diamines Based on Ethambutol as Potential Antituberculosis Preclinical Candidates. J Comb Chem. 2003;5:172–187. doi: 10.1021/cc020071p. [DOI] [PubMed] [Google Scholar]
  • 15.(a) Brown EG, Nuss JM. Alkylation of Rink’s Amide Linker on Polystyrene Resin: A Reductive Amination Approach to Modified Amine-Linkers for the Solid Phase Synthesis of N-Substituted Amide Derivatives. Tetrahedron Lett. 1997;38:8457–8460. [Google Scholar]; (b) Häcker H, Meusel M, Aschfalk M, Gütschow M. Solid-Phase Synthesis of Disubstituted N-Acylureas from Resin-Bound Ureas and Acyl Chlorides. ACS Comb Sci. 2011;13:59–64. doi: 10.1021/co100020b. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES